BindingDB logo
myBDB logout

BDBM454538 US10717746, Example 21

SMILES: CC1(C)Cc2c(cnn2C1)-c1cc(NC(=O)[C@H]2CCC[C@H](C2)NC(=O)C2(O)CC2)ncc1Cl

InChI Key: InChIKey=OJMFGZGCGNGPDF-LSDHHAIUSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 454538   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Cyclin-dependent kinase 9


(Homo sapiens (Human))
BDBM454538
PNG
(US10717746, Example 21)
Show SMILES CC1(C)Cc2c(cnn2C1)-c1cc(NC(=O)[C@H]2CCC[C@H](C2)NC(=O)C2(O)CC2)ncc1Cl |r|
Show InChI InChI=1S/C24H30ClN5O3/c1-23(2)10-19-17(11-27-30(19)13-23)16-9-20(26-12-18(16)25)29-21(31)14-4-3-5-15(8-14)28-22(32)24(33)6-7-24/h9,11-12,14-15,33H,3-8,10,13H2,1-2H3,(H,28,32)(H,26,29,31)/t14-,15+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<3n/an/an/an/an/an/a



ASTRAZENECA AB

US Patent


Assay Description
Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...


US Patent US10717746 (2020)

More data for this
Ligand-Target Pair
Cyclin-dependent kinase 9


(Homo sapiens (Human))
BDBM454538
PNG
(US10717746, Example 21)
Show SMILES CC1(C)Cc2c(cnn2C1)-c1cc(NC(=O)[C@H]2CCC[C@H](C2)NC(=O)C2(O)CC2)ncc1Cl |r|
Show InChI InChI=1S/C24H30ClN5O3/c1-23(2)10-19-17(11-27-30(19)13-23)16-9-20(26-12-18(16)25)29-21(31)14-4-3-5-15(8-14)28-22(32)24(33)6-7-24/h9,11-12,14-15,33H,3-8,10,13H2,1-2H3,(H,28,32)(H,26,29,31)/t14-,15+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<3n/an/an/an/an/an/a



ASTRAZENECA AB

US Patent


Assay Description
Activity of CDK9 was determined in-vitro using a mobility shift assay on a Caliper LC3000 reader (Caliper/PerkinElmer), which measures fluorescence o...


US Patent US10717746 (2020)

More data for this
Ligand-Target Pair